Skip to content

Remote Pregnancy Monitoring to Improve Access

Remote Pregnancy Monitoring to Improve Access: The REACTIVE Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05847790
Acronym
REACTIVE
Enrollment
400
Registered
2023-05-08
Start date
2023-05-25
Completion date
2025-09-26
Last updated
2025-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Monitoring

Keywords

Fetal monitoring, antenatal testing

Brief summary

The goal of this clinical trial is to determine the effectiveness of remote nonstress test (NST) compared to in-clinic NSTs in improving fetal testing completion rates. Participants will be randomized to either in-clinic NSTs or use of an FDA-approved remote monitoring belt for their pregnancy monitoring.

Interventions

DEVICEInvu monitoring belt

INVU monitoring belt used for remote NSTs

OTHERStandard of care

In-clinic NSTs - standard of care

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Singleton pregnancy * Gestational age between 30 weeks 0 days and 35 weeks 6 days * Pregnant patients who have clinical indication for fetal surveillance with NSTs (based on UPHS Health System clinical guidelines for antenatal monitoring) * Able to provide written consent * English speaking

Exclusion criteria

* Multiple gestations * Maternal pre-gravid BMI greater than 45kg/m2 * Presence of an implanted pacemaker or defibrillator * Active abdominal skin infection * A known amniotic fluid index (AFI) less than 5cm or greater than 25cm on the most recent ultrasound (if available) prior to randomization * Delivery is planned within 2 weeks of potential randomization

Design outcomes

Primary

MeasureTime frameDescription
Overall Fetal Testing Completion Ratefrom 32 weeks gestational age to delivery, average of 10 weeks after enrollment.percentage of recommended antenatal testing sessions that were successfully completed as defined as a clinically interpreted test was performed
Fetal Testing Completion Rate in Black versus non-Black subjectsfrom 32 weeks gestational age to delivery, average of 10 weeks after enrollment.Comparison between Black and non-Black subjects' percentage of recommended antenatal testing sessions that were successfully completed as defined as a clinically interpreted test was performed.

Secondary

MeasureTime frameDescription
Obstetrics outcomes: Mode of deliverytime of deliverycategorized as vaginal or cesarean
Fetal Monitoring outcomes: Number of visits to the antenatal testing unitfrom 32 weeks gestational age to delivery, average of 10 weeks after enrollment.Count of visits to the office for in-person monitoring
Fetal Monitoring outcomes: Frequency of provider recommended prolonged monitoringfrom 32 weeks gestational age to delivery, average of 10 weeks after enrollment.Count of number of times provider recommends prolonged monitoring (defined by greater than 40 minutes of time on the monitor).
Fetal Monitoring outcomes: Time on NST monitorfrom 32 weeks gestational age to delivery, average of 10 weeks after enrollment.Sum of the number of minutes the subject is on the NST monitor
Fetal Monitoring outcomes: Number of non-reactive NSTsfrom 32 weeks gestational age to delivery, average of 10 weeks after enrollment.Count of the number of visits
Fetal Monitoring outcomes: Number of biophysical profiles performed for non-reactive NST testsfrom 32 weeks gestational age to delivery, average of 10 weeks after enrollment.Count of the number of biophysical profiles performed for non-reactive NST visits
Fetal Monitoring outcomes: Overall number of visits to the obstetrical triage unitfrom 32 weeks gestational age to delivery, average of 10 weeks after enrollment.Count of the number of visits to the obstetrical triage unit
Fetal Monitoring outcomes: Overall number of visits to the obstetrical triage unit directly related to a fetal monitoring visitfrom 32 weeks gestational age to delivery, average of 10 weeks after enrollment.Count of the number of visit directly related to an outpatient fetal monitoring appointment or session
Fetal Monitoring outcomes: Frequency of recommendation for delivery based on findings on fetal monitoring resultfrom 32 weeks gestational age to delivery, average of 10 weeks after enrollment.Count of the number of subjects in each arm who receive a recommendation for delivery based on the findings of the fetal monitoring results.
Fetal Monitoring outcomes: Number of times a NST is not completed within the prescribed windowfrom 32 weeks gestational age to delivery, average of 10 weeks after enrollment.Count of number of NSTs which occur outside of prescribed window, for example, if a weekly testing regimen is prescribed, an appointment 8 or more days following the last one would count as 1 missed calendar window.
Obstetrics outcomes: Number of participants with an Indication for labor inductiontime of labor inductionin subjects who have labor induction, indication for inducing labor
Obstetrics outcomes: Gestational age at deliverytime of deliverygestational age at time of delivery
Obstetrics outcomes: Composite neonatal morbidity scorefrom delivery to 6 weeks post-deliveryComposite score of neonatal morbidity comprised of one or more of the following: severe respiratory distress, neonatal resuscitation outside of the delivery room, and death. This score could range from 0 to 3 with a higher score meaning a worse outcome
Obstetrics outcomes: Neonatal cord blood pHtime of delivery
Obstetrics outcomes: Apgar scoresfive and ten minutes after deliveryApgar score at five and ten minutes after delivery, the score ranges from 0 to 10 with a higher score meaning a better outcome.
Obstetrics outcomes: Number of participants with an Admission to the neonatal intensive care unitfrom delivery to 6 weeks post-delivery
Obstetrics outcomes: Admission to the neonatal intensive care unit for greater than 48 hoursfrom delivery to 6 weeks post-delivery
Obstetrics outcomes: Maternal length of stayfrom delivery to discharge, up to 6 weeks post-delivery
Obstetrics outcomes: Neonatal length of stayfrom birth to discharge, up to 6 weeks after birth
Cost-effectiveness outcomes: Productivity loss surveyat three timepoints, at time of randomization, 3 weeks after randomization (plus or minus 1 week) and 5 weeks after randomization (plus or minus 1 week)This survey will collect in half days increments the productivity impacts of the pregnancy, NSTs and for seeking health care for those reasons
Cost-effectiveness outcomes: Costsfrom 32 weeks to delivery, average of 10 weeks after enrollment.Costs will be estimated based on collection of data on all health care visits, including outpatient, ED, OB triage and hospital admissions
Implementation outcomes: Theory-informed Acceptability Questionnaireat time of delivery8-item Likert scale with range of values from 8 to 40 with a high score being more acceptable.
Obstetrics outcomes: Number of participants with an Indication for cesarean sectiontime of deliveryin subjects who have a cesarean section delivery, indication for cesarean section
Obstetrics outcomes: Number of participants with Preterm deliverytime of deliverypreterm delivery is defined as less than 37 weeks gestational age

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026